Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-24-013016
Filing Date
2024-01-23
Accepted
2024-01-23 16:31:01
Documents
14

Document Format Files

Seq Description Document Type Size
1 DEFM14A d813099ddefm14a.htm DEFM14A 2073050
2 GRAPHIC g813099g01g01.jpg GRAPHIC 36332
3 GRAPHIC g813099g20g20.jpg GRAPHIC 40401
4 GRAPHIC g813099g32u35.jpg GRAPHIC 103655
5 GRAPHIC g813099g42j24.jpg GRAPHIC 21011
6 GRAPHIC g813099g44q55.jpg GRAPHIC 110721
7 GRAPHIC g813099g51o17.jpg GRAPHIC 623318
8 GRAPHIC g813099g57x37.jpg GRAPHIC 132001
9 GRAPHIC g813099g59f67.jpg GRAPHIC 20030
10 GRAPHIC g813099g81i86.jpg GRAPHIC 20520
11 GRAPHIC g813099g83j81.jpg GRAPHIC 98323
12 GRAPHIC g813099g86h68.jpg GRAPHIC 721083
13 GRAPHIC g813099g96h56.jpg GRAPHIC 200591
14 GRAPHIC g813099sp1a.jpg GRAPHIC 5634
  Complete submission text file 0001193125-24-013016.txt   4964191
Mailing Address 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN MA 02472 617-898-8824
SQZ Biotechnologies Co (Filer) CIK: 0001604477 (see all company filings)

IRS No.: 462431115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-39662 | Film No.: 24553017
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)